GLP-1 & Obesity Drug Brand Directors Email List

2,340+ verified GLP-1 & Obesity Drug Brand Directors contacts. Start with verified baseline email & phone data, then layer optional buyer intent topics and facility technology intelligence to target in-market healthcare decision-makers with total precision.

2,340+ Contacts
September 2026 Verified
99% Accuracy

Real-Time HCP Data Engine

2,340+
Verified GLP-1 & Obesity Drug Brand Directors
MATCH RATE 98.4%
BUYING INTENT 20+ Topics
TECH INTEL Veeva CRM / IQVIA
GROWTH +12.5%
LIVE CONTACT, INTENT & TECH INTELLIGENCE FEED
ACTIVE VERIFICATION
SPECIALIST LOCATION BUYING INTENT STATUS
Dr. Alan Wright Dallas, TX EHR Migration VERIFIED
Dr. Lisa Ray Miami, FL AI Diagnostics VERIFIED
Dr. James Liu Seattle, WA Telehealth Platform VERIFIED
Dr. Robert Kahn Boston, MA Robotic Surgery VERIFIED

Request Your Free Custom Sample

Trusted by Leading Healthcare Organizations

100% Compliant & Secure Outreach

GDPR COMPLIANT
CCPA COMPLIANT
CAN-SPAM ACT COMPLIANT

What Does the GLP-1 & Obesity Drug Brand Directors Email List Look Like?

Every record is a multi-channel asset, containing over 45+ verified data points for precision targeting and high-conversion outreach.

Sample GLP-1 & Obesity Drug Brand Directors Database Preview

DRAG OR SCROLL HORIZONTALLY TO VIEW ALL 18+ VERIFIED, INTENT & TECHNOLOGY INTELLIGENCE COLUMNS
IDContact NameFirst NameLast NameEmail AddressSpecialty / DepartmentPhone NumberFax NumberOrganizationLinkedIn Company PageLinkedIn ProfileAddressCityStateZIP CodeCountryIntent Signal / Active TopicTechnology IntelligenceStatus
MP-10001W**** W****W****W****w****@****.comGLP-1 & Obesity Drug Brand Directors(404) XXX-XXXX(404) XXX-XXXXMedtronic PLClinkedin.com/company/medtronic-plclinkedin.com/in/************ Medical Center DrAtlantaGA30303United StatesHigh (Clinical Trial Systems)Cardiology & Diagnostic SystemsVERIFIED
MP-10002J**** W****J****W****j****@****.comGLP-1 & Obesity Drug Brand Directors(310) XXX-XXXX(310) XXX-XXXXBecton Dickinsonlinkedin.com/company/becton-dickinsonlinkedin.com/in/************ Medical Center DrLos AngelesCA90048United StatesHigh (AI Diagnostics)HST Pathways & RCM SuiteVERIFIED
MP-10003L**** A****L****A****l****@****.comGLP-1 & Obesity Drug Brand Directors(404) XXX-XXXX(404) XXX-XXXXAbbott Laboratorieslinkedin.com/company/abbott-laboratorieslinkedin.com/in/************ Medical Center DrAtlantaGA30303United StatesHigh (RCM Automation)Palo Alto Networks SecurityVERIFIED
MP-10004T**** J****T****J****t****@****.comGLP-1 & Obesity Drug Brand Directors(310) XXX-XXXX(310) XXX-XXXXThermo Fisher Scientificlinkedin.com/company/thermo-fisher-scientificlinkedin.com/in/************ Medical Center DrLos AngelesCA90048United StatesActive (MedTech Procurement)Epic Systems / Cerner EHRVERIFIED
MP-10005D**** M****D****M****d****@****.comGLP-1 & Obesity Drug Brand Directors(404) XXX-XXXX(404) XXX-XXXXJohnson & Johnsonlinkedin.com/company/johnson-johnsonlinkedin.com/in/************ Medical Center DrAtlantaGA30303United StatesHigh (EHR Migration)Nuance & Viz.ai AI DiagnosticsVERIFIED
MP-10006K**** G****K****G****k****@****.comGLP-1 & Obesity Drug Brand Directors(310) XXX-XXXX(310) XXX-XXXXBoston Scientificlinkedin.com/company/boston-scientificlinkedin.com/in/************ Medical Center DrLos AngelesCA90048United StatesActive (Robotic Surgery)Cardiology & Diagnostic SystemsVERIFIED
MP-10007E**** C****E****C****e****@****.comGLP-1 & Obesity Drug Brand Directors(404) XXX-XXXX(404) XXX-XXXXPfizer Inc.linkedin.com/company/pfizer-inc-linkedin.com/in/************ Medical Center DrAtlantaGA30303United StatesHigh (Healthcare Cybersecurity)HST Pathways & RCM SuiteVERIFIED
MP-10008C**** M****C****M****c****@****.comGLP-1 & Obesity Drug Brand Directors(310) XXX-XXXX(310) XXX-XXXXMedtronic PLClinkedin.com/company/medtronic-plclinkedin.com/in/************ Medical Center DrLos AngelesCA90048United StatesMedium (Patient Engagement)Palo Alto Networks SecurityVERIFIED
MP-10009R**** D****R****D****r****@****.comGLP-1 & Obesity Drug Brand Directors(404) XXX-XXXX(404) XXX-XXXXBecton Dickinsonlinkedin.com/company/becton-dickinsonlinkedin.com/in/************ Medical Center DrAtlantaGA30303United StatesMedium (Telehealth Platform)Epic Systems / Cerner EHRVERIFIED
MP-10010S**** T****S****T****s****@****.comGLP-1 & Obesity Drug Brand Directors(310) XXX-XXXX(310) XXX-XXXXAbbott Laboratorieslinkedin.com/company/abbott-laboratorieslinkedin.com/in/************ Medical Center DrLos AngelesCA90048United StatesMedium (Population Health)Nuance & Viz.ai AI DiagnosticsVERIFIED
Download GLP-1 & Obesity Drug Brand Directors Email List Sample & Structure

Get an instant preview of the GLP-1 & Obesity Drug Brand Directors Email List structure or request a free custom sample with real contacts matching your requirements. Access over 50+ verified data fields for this list.

100% NPI Matched
88%+ Direct Dial Rate
HIPAA & CAN-SPAM Compliant
1:1 Hard Bounce Replacement Guarantee

Precision Filters for GLP-1 & Obesity Drug Brand Directors Email List Outreach

Precision-engineer your outreach using organization-level attributes and verified professional markers verified at the point of care.

Geography

Country, state, city, metro, and ZIP-level targeting for GLP-1 & Obesity Drug Brand Directors.

Role Seniority

Target GLP-1 & Obesity Drug Brand Director practitioners, leads, and decision-making directors.

SUB-SPECIALTY GLP-1 & OBESI... PRESCRIBING HABITS PATIENT VOLUME

Advanced Clinical Targeting

Go beyond job titles. Filter by specific GLP-1 & Obesity Drug Brand Director sub-specialties, prescribing habits, patient volumes, clinical procedure focus, and active buying intent signals.

Data Fields

Core contact schema or extended 50+ field enrichment profiles.

Practice Setting

Private practice, hospital networks, or academic institutions.

Intent Signal Configurator (Optional Add-on)

Which signals should I layer on the GLP-1 & Obesity Drug Brand Directors list?

Select your campaign type below — we'll show you the highest-value intent signals for this audience.

Technology Intelligence Configurator (Optional Add-on)

Which software & facility equipment filters match your campaign?

Select a technology focus below — see recommended software adoption and medical equipment filters for GLP-1 & Obesity Drug Brand Directors.

Ready to Activate Your Intent-Targeted Campaign?

Select a campaign type above, then request your custom intent-filtered segment. Our data team will share counts, pricing & a free sample within 24 hours.

CSV / Excel
API Ready

Why GLP-1 & Obesity Drug Brand Directors Email List Targeting Requires Specialty-Level Precision

Various GLP-1 & Obesity Drug Brand Director professionals often share the same broad specialty code, but their purchasing needs and clinical interests are vastly different. Reaching the right specialist requires data built with sub-specialties and clinical focus areas, practice setting, organizational affiliation, and active buying intent filters.

Procedural Specialization

Generic databases conflate different GLP-1 & Obesity Drug Brand Director specialists. We segment by procedure volume to match your portfolio to the right clinicians.

Clinical & Prescribing Focus

Pharma and MedTech teams targeting GLP-1 & Obesity Drug Brand Director practitioners need different profiles. We filter by clinical scope and prescribing authority.

Practice Setting & Affiliation

Academic hospitals and private GLP-1 & Obesity Drug Brand Director clinics operate under different procurement models. We map organizational affiliation to reach true decision-makers.

Who Are GLP-1 & Obesity Drug Brand Directors?

A deep dive into the audience profile, systemic influence, and institutional purchasing authority.

GLP-1 & Obesity Drug Brand Directors oversee the marketing, commercial launch, physician engagement, and supply chain strategy for glucagon-like peptide-1 (GLP-1) and dual GIP/GLP-1 receptor agonist therapeutics. As medications like semaglutide, tirzepatide, and next-generation oral incretins expand from type 2 diabetes and obesity into cardiovascular protection, sleep apnea, MASH liver disease, and osteoarthritis, these brand teams command the largest commercial marketing budgets in pharmaceutical history.
We maintain verified records for 2,340+ commercial brand directors, product marketing vice presidents, and metabolic commercialization leads. Collaborating with Pharmaceutical Sales Reps and Obesity Medicine Specialists, these executives evaluate digital adherence companion apps, patient onboarding programs, and specialized auto-injector packaging.
Verified
Dr. Samantha Reed
Sr. GLP-1 & Obesity Drug Brand Director
Dr. Michael Evans
Board Certified

What Is the GLP-1 & Obesity Drug Brand Directors Email List?

Verified datasets engineered for precision outreach, clinical alignment, and enterprise-scale conversion.

The GLP-1 & Obesity Drug Brand Directors Email List provides direct contact information for executives directing metabolic drug commercialization. Filter records by manufacturer (pharma innovators vs.
specialized clinical biotechs), formulation (subcutaneous injectable vs. oral peptide), indication phase, and geographic territory.

Integrated Data Matrix

Precision Coverage

  • GLP-1 & Obesity Drug Brand Director Email Address
  • GLP-1 & Obesity Drug Brand Director Direct Dial Number
  • Company/Facility Main Phone Number
  • GLP-1 & Obesity Drug Brand Director LinkedIn Profile URL
  • Organization/Facility Name
  • City, State/Province, Country
Contact Profile
Verified GLP-1 & Obesity Drug Brand Directors Email Database
Database Selection CONTACT NAME EMAIL ADDRESS STATUS DDr. Samantha ReedGLP-1 & Obesity Drug B..[email protected]ACTIVEMMarcus ThorneGLP-1 & Obesity Drug B..[email protected]ACTIVEEElena RodriguezGLP-1 & Obesity Drug B..[email protected]ACTIVEDDr. Julian VanceGLP-1 & Obesity Drug B..[email protected]ACTIVESSarah JenkinsGLP-1 & Obesity Drug B..[email protected]ACTIVEDDr. Omar HassanGLP-1 & Obesity Drug B..[email protected]ACTIVELLinda ParkGLP-1 & Obesity Drug B..[email protected]ACTIVERRobert WalshGLP-1 & Obesity Drug B..[email protected]ACTIVE

Campaign Reach & ROI Calculator

Simulate your potential campaign reach and pipeline value using the active counts for the GLP-1 & Obesity Drug Brand Directors database.

Adjust Campaign Inputs

Target List Size 2,340
Outreach Open Rate 25%
Reply-to-Meeting Rate 1.5%
Average Contract Value (ACV) $15,000

Projected Campaign Value

Projected Email Opens
585
Estimated Demos / Meetings
9
Estimated Pipeline Opportunity
$26,325

*Assumes a conservative 20% sales close rate from booked demos.

What to Look for in a Healthcare Data Vendor

Use these criteria to evaluate any provider - including us. The right list vendor should meet all of them.

Evaluation CriteriaWhat Good Looks LikeMedicalProspects
Data FreshnessMonthly verification minimum, sourced from multiple primary channelsMonthly refresh from 120+ verified healthcare data sources
Contact CompletenessDirect professional email + direct dial, not just main switchboard numberProfessional email, direct dial, org phone, and LinkedIn URLs per record
Regulatory ClassificationFilter by FDA Class I/II/III or clinical trial phaseTherapeutic area, pipeline stage, and device class filters included
Business Function MappingSeparation of commercial sales/marketing from medical and R&D rolesCommercial, medical affairs, R&D, and regulatory affairs segmented cleanly
Research Site SegmentationDifferentiates CRO organizations, sponsors, and investigator sitesMapped CRO/Sponsor/Site database with site-specific roles
Buyer Intent SignalsNot available or limited to generic web traffic without healthcare contextOptional add-on across all lists: 20+ healthcare intent topics (EHR, AI, MedTech, RCM)
Bounce Protection1:1 hard-bounce replacement guaranteed in writing, not "best effort"99% deliverability guarantee + 1:1 replacement at no extra cost
List Build ApproachCustom-built to your campaign brief, not generic pre-packaged segment downloadsEvery list built fresh to your exact criteria and delivered in 24–48 hours
ComplianceGDPR and CAN-SPAM suppression controls documented and included with deliveryFull suppression controls and compliance documentation included

Questions We Hear Most

Quick, practical answers based on how teams usually buy and use healthcare audience data.

What contact data fields are provided in the GLP-1 & Obesity Drug Brand Directors Email List?

With the GLP-1 & Obesity Drug Brand Directors Email List, you receive direct professional emails, direct-dial phone numbers, corporate lines, LinkedIn profile links, and up to 50+ enrichment fields per record. For pharma and biotech records, company type (large pharma, emerging biotech, specialty), business function (commercial, medical affairs, regulatory, R&D), and therapeutic area focus are also included. Our dataset is refreshed monthly via 120+ primary healthcare data channels.

Is it possible to filter this GLP-1 & Obesity Drug Brand Directors Email List to fit our specific campaign target?

Absolutely. We do not sell static databases. Every file is tailored to order using criteria like therapeutic area / function, facility specs, geographic region, and job titles to fit your pipeline.

Can I filter GLP-1 & Obesity Drug Brand Directors by therapeutic area and business function?

Yes. Therapeutic area (oncology, cardiology, CNS, immunology, rare disease, and others) and business function (commercial, medical affairs, regulatory, R&D, market access) filters can be combined. A campaign targeting oncology commercial teams requires very different contacts than one targeting regulatory affairs directors at the same companies — functional role segmentation prevents that overlap.

How accurate is the pharma and biotech contact data?

Pharmaceutical and biotech records are verified monthly against corporate directory validation, commercial database cross-referencing, and direct organizational verification for field-based contacts (MSLs, sales representatives, KAMs). Commercial team contacts — which turn over most frequently in pharma — are re-verified on a 60-day cycle. We target 99% deliverability with 1:1 hard-bounce replacement at no cost.

Does the GLP-1 & Obesity Drug Brand Directors Email List support multi-channel outreach across email, phone, and LinkedIn?

Yes. Each contact record includes a professional email address, direct dial number, organization phone number, and LinkedIn profile URL — so your team can run coordinated email, phone, and social outreach from a single verified dataset. For vendors selling to pharmaceutical and biotech commercial teams, LinkedIn is a particularly high-engagement channel with this audience.

What are the 3 layers of Healthcare Audience Intelligence?

MedicalProspects delivers 3 complementary intelligence layers: (1) Verified Contact Intelligence (standard baseline on all lists: direct emails, phone lines, NPI pairing, facility hierarchy), (2) Healthcare Buyer Intent Data (optional add-on: 20+ active research topics), and (3) Healthcare Technology Intelligence (optional add-on: software adoption & facility medical equipment insights).

How do Intent Data and Technology Intelligence work as optional add-ons?

Your base list always comes with 100% verified contact details. Depending on your go-to-market strategy, you can choose to enrich your custom list with active Buyer Intent Data to target in-market buyers, or Technology Intelligence to match installed software and facility equipment criteria.

Why Our GLP-1 & Obesity Drug Brand Directors Database Outperforms Generic Lists

We don't sell generic B2B lists. Our healthcare data is verified, targeted, and built specifically for medical outreach.

120+ Verified Sources

Every GLP-1 & Obesity Drug Brand Director record is cross-validated across 120+ trusted data sources before delivery - not assembled from a single aggregator feed.

99%+ Deliverability Guarantee

Hard-bounce replacement included on every GLP-1 & Obesity Drug Brand Director order. If deliverability falls below 99%, we replace the affected records.

Fully Compliant Processing

Suppression-aware processing for GLP-1 & Obesity Drug Brand Directors datasets to support CAN-SPAM, GDPR, and CCPA-conscious outreach.

NPI-Cross-Referenced

GLP-1 & Obesity Drug Brand Director professional records are cross-checked against NPI registry data for specialty accuracy and identity verification.

Practice Setting Segmentation

Hospital-employed, private practice, and academic GLP-1 & Obesity Drug Brand Director contacts are separated cleanly for targeted messaging.

Specialty Depth Beyond Title

Multi-level specialty filtering from primary practice area to subspecialty for precise GLP-1 & Obesity Drug Brand Director audience segmentation.

Classification Registry

FDA Establishment FEI Registration

Every professional contact profile is mapped directly to standard federal and taxonomy datasets to guarantee compliance and targeting fidelity.

Active Registry Code
TAX-7240
Status: Active
Verified: Within 30 Days

Recent Buyer Reviews

What marketing and sales teams say after running campaigns with our data.

★★★★★

Needed to launch a new orthopedic implant. Sourced 52,000 targeted orthopedic surgeons and hospital purchasing contacts. The multi-channel outreach achieved a 38% open rate, 8.7% click rate, 5.4% reply rate, and generated 186 meetings ($2.9M pipeline) with 27 new customers.

View Full Case Study
VC
Verified Case Study Orthopedic Implant Launch Campaign Medical Device Manufacturer
★★★★★

Promoted a Continuing Medical Education webinar to 31,000 Cardiologists. Sourced verified cardiology lists that achieved 9,600 opens, 2,200 registrations, and 1,480 attendees (a 67% attendance rate) resulting in 42 post-event meetings.

View Full Case Study
VC
Verified Case Study Cardiologist CME Webinar Campaign Pharma Marketing Agency
★★★★★

Targeted 16,000 Radiologists across 7 regional campaigns. Generated 219 demo requests for a new diagnostic imaging system, leading to 44 equipment installations.

View Full Case Study
VC
Verified Case Study New Imaging System Launch Diagnostic Equipment Manufacturer

Geographic Density & Audience Distribution

Outbound targeting performs best when aligned with state-level provider density. The GLP-1 & Obesity Drug Brand Directors database is mapped to active physical and mailing registry structures across North America.

Below is the active proportional breakdown of contacts in the top six states by provider density, derived from NPI data verification logs.

Proportional Density by State

New Jersey 12.3%
North Carolina 6.2%
Texas 6.6%
Massachusetts 13.0%
California 16.4%
Pennsylvania 8.0%

How Our Customers Use Our GLP-1 & Obesity Drug Brand Directors Email List

These are the most common use cases -but we can tailor the data to match your exact goals.

Digital Companion Apps & Nutritional Habit Coaching

Selling digital lifestyle tracking apps, dietitian telehealth integration, or muscle mass retention companion programs? Pitch brand heads maximizing therapy longevity.

Direct-to-Consumer (DTC) Media & Healthcare Advertising

Marketing omnichannel television media, programmatic digital advertising, or social media influencer campaigns? Reach brand directors deploying multi-million dollar ad budgets.

Specialty Auto-Injector Pens & Cold-Chain Packaging

Offering ergonomic prefilled pen devices, smart connected dose-trackers, or temperature-monitored mailers? Connect with drug delivery engineers.

Payer Market Access & Obesity Formulary Coverage Strategy

Providing employer opt-in benefit modeling, Medicare coverage advocacy data, or PBM rebate analysis? Reach commercial access directors.

Physician Detailing & Medical Education on Muscle Preservation

Marketing hybrid rep detailing platforms, medical education on lean mass retention, or prescriber webinars? Pitch sales training leaders.

Metabolic Disease & Obesity Commercialization Summits

Promoting obesity therapeutics conferences, commercial launch webinars, or metabolic pipeline briefings? Connect with active brand executives.

Quick Answer

The GLP-1 & Obesity Drug Brand Directors Email List from MedicalProspects provides verified glp-1 & obesity drug brand directors contacts with therapeutic area, business function, and pipeline stage filters — monthly-verified across pharma, biotech, and CRO organizations for commercial, medical affairs, and regulatory vendor campaigns.

E-E-A-T Verified Review Data Confirmed

MedicalProspects Data Team

Healthcare Audience Specialists - Life Sciences & Pharma

Our data team has reviewed the GLP-1 & Obesity Drug Brand Directors page and confirmed that all audience counts, data field descriptions, and targeting attributes are accurate as of the last verification cycle. This page was reviewed by the MedicalProspects data team - healthcare audience specialists with 100+ years of combined experience sourcing, verifying, and delivering medical contact data for B2B campaigns. The team manages relationships with 120+ verified healthcare data channels and supports hundreds of outbound campaigns across pharma, medtech, health IT, and healthcare services annually.

100+
Years Combined Experience
120+
Verified Data Channels
1,000s
Campaigns Supported
300+
Healthcare Audience Segments

Want This Audience Customized? We Can Do That.

Share your non-negotiable filters and we'll deliver a campaign-ready file built for your exact use case.

Request Your List